← Browse by Condition
Medical Condition

best vitelliform macular dystrophy

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT07185256 Phase 1, Phase 2
Recruiting

Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)

Enrollment
10 pts
Location
United States
Sponsor
Opus Genetics, Inc
View Trial →